Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review.
Westerveld ASR, van Dalen EC, Asogwa OA, Koopman MMW, Papadakis V, Laureys G, van der Pal HJH, Kremer LCM, Tytgat GAM, Teepen JC.
Westerveld ASR, et al. Among authors: van dalen ec, van der pal hjh.
Cancer Treat Rev. 2022 Mar;104:102355. doi: 10.1016/j.ctrv.2022.102355. Epub 2022 Feb 7.
Cancer Treat Rev. 2022.
PMID: 35158111
Review.